EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing RNA encapsulation quantification in lipid nanoparticles: Sustainable alternatives to Triton X-100 in the RiboGreen assay

David Schultz, Rasmus D Münter, Alex M Cantín, Paul J Kempen, Nadin Jahnke, Thomas L Andresen, Jens B Simonsen, Andrew J Urquhart

European Journal of Pharmaceutics and Biopharmaceutics · 2024-12 · 205 · 114571

DOI: 10.1016/j.ejpb.2024.114571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024-12. Verfasst von David Schultz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. Hauptthemen laut MEDLINE: Octoxynol, Nanoparticles, Lipids, Surface-Active Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To quantify concentration and encapsulation efficiency (EE) of mRNA in lipid nanoparticles (LNPs) the RiboGreen assay is extensively used. As part of this assay, a surfactant is used to release mRNA from LNPs for detection with the RiboGreen dye. So far, the surfactant of choice has been Triton X-100, which is harmful to human health and the environment. Alternatives to Triton X-100 are therefore needed, but surprisingly no such effort has yet been described in the literature. Here we show how three, less harmful, surfactants (Brij 93, Zwittergent 3-14 and Tween 20) compare to Triton X-100 for releasing mRNA from LNPs for detection with the RiboGreen assay. We found that Zwittergent 3-14 and Tween 20 at high concentrations (0.5 %) are at the minimum as effective as Triton X-100 at high concentration (0.5 %) across three different mRNA-LNP formulations. Interestingly, Tween 20 was the most effective at releasing mRNA from LNPs, across all concentration ranges explored (0.0025 %, 0.01 %, 0.1 % and to 0.5 % (v/v)) highlighting its potency at solubilizing the three different LNP formulations. Our results show that Tween 20 can be used as an alternative to Triton X-100 in the RiboGreen assay, resulting in more accurate quantification of the total mRNA concentration and EE%, as well as making the assay more environmentally friendly. Such improvement could potentially increase the likelihood of identifying therapeutically attractive hard-to-solubilize LNP-mRNA formulations that would be discharged when using Triton X-100 due to their apparent low EE values, as well as ensure more accurate mRNA dosing in both in vitro and in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OctoxynolNanoparticlesLipidsSurface-Active AgentsRNA, MessengerPolysorbatesHumansLiposomes

Stichwörter der Autor:innen

Encapsulation efficiencyLipid nanoparticlesNucleic acidsRiboGreenSurfactants Triton X-100mRNA

Substanzen

OctoxynolLipidsSurface-Active AgentsRNA, MessengerPolysorbatesLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
  • Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark; National Centre for Nano Fabrication and Characterization, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
  • Department of Non-viral Delivery, Novo Nordisk A/S, 2760 Måløv, Denmark.
  • Jbsimonsen Consult, 2830 Virum, Denmark.
  • Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. Electronic address: anur@dtu.dk.

Förderung

  • Novo Nordisk Foundation
  • Lundbeck Foundation

Zitieren

APA

Schultz, D., Münter, R. D., Cantín, A. M., Kempen, P. J., Jahnke, N., Andresen, T. L., Simonsen, J. B., & Urquhart, A. J. (2024). Enhancing RNA encapsulation quantification in lipid nanoparticles: Sustainable alternatives to Triton X-100 in the RiboGreen assay. European Journal of Pharmaceutics and Biopharmaceutics, 205, 114571. https://doi.org/10.1016/j.ejpb.2024.114571

Vancouver

Schultz D, Münter RD, Cantín AM, Kempen PJ, Jahnke N, Andresen TL, et al. Enhancing RNA encapsulation quantification in lipid nanoparticles: Sustainable alternatives to Triton X-100 in the RiboGreen assay. European Journal of Pharmaceutics and Biopharmaceutics. 2024;205:114571. doi:10.1016/j.ejpb.2024.114571

BibTeX
@article{Schultz2024,
  author = {Schultz, David and Münter, Rasmus D and Cantín, Alex M and Kempen, Paul J and Jahnke, Nadin and Andresen, Thomas L and Simonsen, Jens B and Urquhart, Andrew J},
  title = {Enhancing RNA encapsulation quantification in lipid nanoparticles: Sustainable alternatives to Triton X-100 in the RiboGreen assay},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2024},
  volume = {205},
  pages = {114571},
  doi = {10.1016/j.ejpb.2024.114571}
}
Kostenlos starten →